Hemoglobin A1c is used clinically as a biomarker for the diagnosis and management of diabetes mellitus. Various methods are available to measure HbA1c and each has advantages and limitations. The focus of this presentation is on the clinical and operational aspects of using capillary electrophoresis as an analytical method for HbA1c measurement. Learning Objectives
Dr. Grenache is the chief scientific officer for TriCore Reference Laboratories in Albuquerque, New Mexico. In that role, he leads the TriCore Research Institute and works cooperatively to develop and implement TriCore’s scientific research strategy. He is also the medical director of the chemistry, immunology, and esoteric analytic chemistry labs, a clinical professor of pathology at the University of New Mexico, and president of the American Association for Clinical Chemistry. He is a diplomate of the American Board of Clinical Chemistry and a Fellow in the AACC Academy. His research interests are centered on leveraging longitudinal laboratory data to gain insights into population health and the diagnostic tests used to manage the pregnant patient.
Evolution makes the difference.
The power of up to 36 capillaries in one automated high volume workcell.
The compact and affordable automation of Capillary Electrophoresis.
Uncompromized HbA1c Results.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.